Brief: Aptose Biosciences Inc Files For Resale Of Up To 1.26 mln Common Shares By Selling Shareholder - SEC Filing
20/06/2023 11:37
June 20 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE BIOSCIENCES INC FILES FOR RESALE OF UP TO 1.26
MILLION
COMMON SHARES BY SELLING SHAREHOLDER - SEC FILING
Further company coverage: APS.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting